Australia Launches Royal Commission Into Antisemitism After Bondi Beach Hanukkah Attack 
Pentagon to Halt Ivy League Programs for U.S. Military Officers Starting 2026 
Trump Approves FEMA Emergency Declaration After Massive Potomac River Sewage Spill 
Federal Judge Blocks Virginia Social Media Age Verification Law Over First Amendment Concerns 
NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation 
FERC Approves Blackstone Infrastructure’s Acquisition of TXNM Energy, Advancing Utility Merger 
Dominican Republic Unveils Massive Rare Earth Deposits to Boost High-Tech and Energy Sectors 
Samsung Stock Hits Record High on Nvidia HBM4 Supply Deal, Boosting AI Chip Rally 
Argentina Senate Approves Bill to Lower Age of Criminal Responsibility to 14 
Anthropic Resists Pentagon Pressure Over Military AI Restrictions 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Netanyahu Suggests Iran’s Supreme Leader Khamenei May Have Been Killed in Israeli-U.S. Strikes 
Nintendo Share Sale: MUFG and Bank of Kyoto to Sell Stakes in Strategic Unwinding 
FCC Approves Charter Communications’ $34.5 Billion Acquisition of Cox Communications 
Venezuela Amnesty Law Frees Nearly 2,200 Prisoners, Says Jorge Arreaza 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Israel Declares State of Emergency as Iran Launches Missile Attacks 
U.S. President Donald Trump has signed an executive order aimed at expanding the use of artificial intelligence (AI) in pediatric cancer research. The order provides an additional $50 million in research grants to accelerate progress in finding cures for childhood cancers, according to White House officials.
This move builds on the National Cancer Institute’s (NCI) Childhood Cancer Data Initiative, a decade-long, $500 million program launched in 2019 to collect and share vital data on pediatric cancers. Michael Kratsios, director of the White House Office of Science and Technology Policy, highlighted that childhood cancer remains the leading cause of disease-related deaths among children in the United States, with cases rising more than 40% since 1975.
Kratsios noted that advances in AI can now be harnessed to sharpen diagnoses, improve clinical trials, fine-tune treatment strategies, and enhance prevention methods. Data gathered through the NCI initiative is expected to empower researchers with new tools to tackle the complexity and diversity of pediatric cancers.
In addition to the $50 million in grants, the National Institutes of Health (NIH) will double its commitment by investing another $50 million. This funding aims to attract leading scientific teams through competitive research opportunities. Further investments are also anticipated to strengthen ongoing initiatives.
The announcement comes despite Trump’s 2026 budget proposal, which suggested a 37% cut to the NCI budget. Lawmakers in both the House and Senate, however, have pushed back against these cuts, and budget negotiations remain ongoing.
Globally, the World Health Organization reports that around 400,000 children and adolescents are diagnosed with cancer each year. While advances in adult cancer research have surged with AI, pediatric cancer research has lagged due to challenges like cancer rarity, diversity, and ethical concerns over patient data protection.
By reinforcing funding and leveraging AI, the administration aims to close this gap and accelerate life-saving innovations in childhood cancer treatment.
